PK Study of IV Formulation of GW856553

NCT01039961 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Disease

Interventions

DRUG: losmapimod 1 mg
DRUG: losmapimod
DRUG: losmapimod 15 mg

Sponsor

GlaxoSmithKline